Crescent Biopharma, Inc.

Healthcare

NASDAQ:CBIO · NASDAQ Capital Market

Market Cap $487.75M Beta 1.15 P/E (TTM) -3.3

$17.69 -2.69%

-$0.49 today

52W Low $8.72High $27.41

Vol 0.11M · Avg 0.28M

EPS (TTM) -$5.33Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+15.62%

Period High

$26.98

Period Low

$8.94

Latest

$17.69

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

C4 Therapeutics, Inc.

NASDAQ:CCCC

$330.07M

OmniAb, Inc.

NASDAQ:OABI

$257.83M

Armata Pharmaceuticals, Inc.

AMEX:ARMP

$253.67M

Tonix Pharmaceuticals Holding Corp.

NASDAQ:TNXP

$191.29M

Compugen Ltd.

NASDAQ:CGEN

$188.63M

Innate Pharma S.A.

NASDAQ:IPHA

$169.96M

Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

$143.33M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$72.87M

Heron Therapeutics, Inc.

NASDAQ:HRTX

$63.11M

Vyome Holdings, Inc.

HIND

$12.61M

What is the latest CBIO filing?

The latest filing shown is 8-K dated Jun 16, 2026.

How many recent filings does CBIO have?

Intrinsic Alpha currently shows 20 recent filings for CBIO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.